Topics › Health Sciences › Medicine › Oncology
CAR-T cell therapy research Sign in to save
Papers per year
Papers 177
Open in paper search →-
Atalanta-1: A Phase 1/2 Trial of GLPG5101, a Fresh, Stem-like, Early Memory CD19 CAR T-Cell Therapy with a 7-Day Vein-to-Vein Time, for the Treatment of Relapsed/Refractory Non-Hodgkin Lymphoma
Marie José Kersten, Kirsten Saevels, Évelyne Willems, Marte C. Liefaard, Stavros Milatos, Margot J. Pont, +9 more
3citations -
High complete response rates and minimal residual disease (MRD) negativity, with durable responses, in high-risk mantle cell lymphoma (MCL) with GLPG5101, a fresh, early memory-enriched CAR T-cell therapy with a 7-day vein-to-vein time: Results from the ATALANTA-1 MCL cohort
Marie José Kersten, Joost S.P. Vermaat, Pim G. N. J. Mutsaers, Maria Theresa Kuipers, Évelyne Willems, Sébastien Anguille, +14 more
3citations -
Solid tumor-on-chip model for efficacy and safety assessment of CAR-T cell therapy2023 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine CAR-T cell therapy research Open access
Tengku Ibrahim Maulana, Claudia Teufel, Madalena Cipriano, Lisa Lazarevski, Francijna E. van den Hil, Valeria V. Orlova, +4 more
2citations -
High complete response rates, low dropout rate, and low-grade toxicities in patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) receiving GLPG5101, a fresh, early memory-enriched CAR T-cell therapy with a 7-day vein-to-vein time: Results from the ATALANTA-1 DLBCL cohort
Joost S.P. Vermaat, Pim G. N. J. Mutsaers, Sébastien Anguille, Maria Theresa Kuipers, Évelyne Willems, Tim J. A. Dekker, +13 more
2citations -
465 | LOW RATES OF HIGH‐GRADE TOXICITIES WITH GLPG5101, A FRESH, STEM‐LIKE, EARLY MEMORY PHENOTYPE ANTI‐CD19 CAR T‐CELL THERAPY IN PATIENTS WITH NHL IN THE ATALANTA‐1 STUDY
Joost S.P. Vermaat, Sébastien Anguille, Maria Theresa Kuipers, Pim G. N. J. Mutsaers, E. Willems, Michael Russell Bishop, +9 more
1citations -
Patient‐Specific Determinants of Response to BCMA ‐ and GPRC5D ‐Targeted CAR T‐Cell Therapy in Multiple Myeloma: A QSP Analysis of Clinical Trial and Real‐World Data
Vasiliki Kostiou, Vijayalakshmi Chelliah, Piet H. van der Graaf, Andrzej M. Kierzek, Tasmin Farzana, Sham Mailankody, +1 more
1citations
Most active Aachen authors
-
Joost S.P. Vermaat 3,482 citations overall24 papers
-
Mirjam H.M. Heemskerk 10,104 citations overall22 papers
-
John B.A.G. Haanen 103,733 citations overall18 papers
-
Renate S. Hagedoorn 2,657 citations overall18 papers
-
Jarl Mooyaart 291 citations overall13 papers
-
Marieke Griffioen 4,156 citations overall12 papers
-
Dennis F.G. Remst 1,178 citations overall12 papers
-
Jorinde Desiree Hoogenboom 222 citations overall12 papers
-
Peter A. van Veelen 18,468 citations overall11 papers
-
J.H. Frederik Falkenburg 12,934 citations overall11 papers
-
Michel G.D. Kester 5,796 citations overall11 papers
-
Tim J. A. Dekker 1,711 citations overall10 papers
-
Anne K. Wouters 476 citations overall10 papers
-
Sophie Vermond 3 citations overall9 papers
-
Gemma Moiset 508 citations overall8 papers